SPRI | Balloon Pulmonary Angioplasty In Patients With CTEPH (2022 EN)

Discussion in 'Medicine' started by Kanka, Sep 21, 2022.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,391
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Francesco Saia (Editor), Nazzareno Galiè (Editor), Hiromi Matsubara (Editor),
    Full Title: Balloon Pulmonary Angioplasty In Patients With CTEPH
    Publisher: Springer; 1st ed. 2022 edition (June 28, 2022)
    Year: 2022
    ISBN-13: 9783030959975 (978-3-030-95997-5), 9783030959968 (978-3-030-95996-8)
    ISBN-10: 303095997X, 3030959961
    Pages: 130
    Language: English
    Genre: Medicine: Internal Medicine
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 117.69 €


    The only curative treatment currently available for chronic thromboembolic pulmonary hypertension (CTEPH) is surgical pulmonary endoarterectomy (PEA). However, several patients may have high risk factors for surgery, or a peripheral disease not amenable to surgical treatment; or else a residual pulmonary hypertension after PEA. Balloon pulmonary angioplasty (BPA) was recently developed to offer an alternative treatment for these patients. Extensive data has since confirmed the efficacy and relative safety of this procedure. However, there are several technical issues that have yet to be resolved. In addition, many cardiologists and pneumologists still know very little about the procedure itself and its potential.

    Exploring the clinical indications and technical aspects of BPA, this book offers a valuable reference guide for all those who would like to introduce or improve a BPA program, and for all those whose work involves treating this complex patient population.


    Overview:
    ✓ Describes a novel treatment still poorly known and not yet standardized
    ✓ Of interest for an interdisciplinary audience
    ✓ Uniquely, covers balloon pulmonary angioplasty in patients with CTEPH

    -------------